Eurofins, FR0014000MR3

Eurofins Scientific SE highlights its global testing role as investors watch sector trends

Published on 07/06/2026 at 12:14 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Eurofins Scientific SE continues to expand its laboratory network and digital capabilities, underscoring its role in global testing and inspection markets while investors compare its growth profile with large US health-care peers.

Eurofins, FR0014000MR3, Illustration mit AI erstellt.
Eurofins, FR0014000MR3, Illustration mit AI erstellt.

Eurofins Scientific SE (ISIN FR0014000MR3) is one of the largest independent laboratory groups worldwide, with a broad footprint in testing, inspection and certification services across health care, food, environmental and pharmaceutical markets.

The company operates a diversified portfolio of laboratories that provide analytical services for clients ranging from drug makers and hospitals to food producers, industrial manufacturers and public authorities.

Global laboratory network and services

Eurofins Scientific SE has built a large international network of laboratories that support customers with routine and specialized testing services in many countries.

Its activities span clinical diagnostics, food and feed testing, environmental analysis, pharmaceutical quality control, and materials testing for industrial clients.

The group has grown over the years through organic expansion and acquisitions, integrating specialized laboratories into its wider platform.

Positioning versus major health-care peers

For investors, one reference point is the broader health-care and diagnostics sector, including large US companies that provide laboratory services to hospitals and physicians.

Eurofins Scientific SE competes globally for contracts that involve high-volume testing as well as complex analytical work, and its diversified client base can help balance demand across regions and end markets.

Go deeper

Explore Eurofins Scientific SE in more detail

Eurofins Scientific SE publishes investor information and financial reports that outline its strategy, acquisitions and laboratory network.

Representative business line

A representative part of Eurofins Scientific SE's activity is the provision of routine and specialized laboratory tests that support clinical diagnostics, drug development and food safety controls.

Stock and listing overview

Eurofins Scientific SE is listed on a European stock exchange, and its shares reflect investor expectations for growth in demand for analytical and laboratory services.

Eurofins Scientific SE key data

  • Company: Eurofins Scientific SE
  • ISIN: FR0014000MR3
  • Ticker: Not specified
  • Exchange: European listing
  • Price (as of latest available data): Not specified
  • Market cap: Not specified
  • Sector / Industry: Health-care, testing and laboratory services
  • Index membership: Not specified
  • Next earnings date: Not yet officially scheduled

Find out more on social platforms

This article was generated automatically and technically reviewed before publication. Market prices, analyst data and company information are provided without warranty and may change at short notice. This content is for informational purposes only and is not investment, financial, legal or tax advice. It is not a recommendation to buy or sell any security. Investing in securities involves risk, including the possible loss of principal.

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | FR0014000MR3 | EUROFINS | boerse | 69704315 | bgmi